Market Currents
Shares of Anthera Pharmaceuticals (ANTH -52.1%) can't stop the freefall that was triggered by...
-
Monday, March 12, 2012, 12:07 PM ETShares of Anthera Pharmaceuticals (ANTH -52.1%) can't stop the freefall that was triggered by Friday's announcement that it's canceling its late-stage trial of its experimental treatment for heart disease. Adam Feuerstein eyes the recent carnage with a number of biotech names to conclude that "fail" is now re-entering the lexicon of investors in the sector.
Other date
Latest Articles
